XenoPort, Inc. (XNPT)
$16.45
-0.20 (-1.20%)
| CAPS Rating |
|
|---|---|
| Open | $16.17 |
| Previous Close | $16.65 |
| Daily Range | $16.16 - $16.61 |
| 52-Week Range | $13.36 - $32.00 |
| Market Cap | $499.1M |
| P/E Ratio | 47.05 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 109,752 |
| Average Daily Volume | 421,000 |
XNPT
VS S&P 500 (SPY)
How do you think XNPT will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
XNPT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
XNPT News and Commentary
- Music to Health-Care Investors' Ears – The Motley Fool
- 3 Companies Looking for Gratitude Early – The Motley Fool
- A 25% Stock Gain Will Ease Any Pain – The Motley Fool
- UPDATE 1-XenoPort says pain drug meets main goal of trial – Reuters
- Updated FDA Calendar of Decision Dates – Blog at The Motley Fool
Related News and Articles
- A Mostly Meaningless FDA Approval – The Motley Fool
- Biotech Bargains for Your Portfolio – The Motley Fool
- 7 of the Most Efficient Companies on the Planet – The Motley Fool
- 5-Star Stocks Poised to Pop: Diageo – The Motley Fool
- 3 China Profit Plays – The Motley Fool
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
RSS Headlines
Fool UK
